CDK4 as a Phytochemical Based Anticancer Drug Target

doi 10.1101/859595
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Tyrosyl-Dna Phosphodiesterase 1 as a Target for Anticancer Therapy

2013English

CDK4 Expression in Chordoma: A Potential Therapeutic Target Running Title: CDK4 Expression in Chordoma

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2017English

Transcription Factor-Based Drug Design in Anticancer Drug Development

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1997English

Phytochemical Importance of Medicinal Plants as Potential Sources of Anticancer Agents

Doga, Turkish Journal of Botany
Plant Science
2014English

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Environmentally Responsive Peptides as Anticancer Drug Carriers☆

Advanced Drug Delivery Reviews
Pharmaceutical Science
2009English

Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs.

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy